Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1965 5
1966 1
1967 2
1970 1
1971 2
1972 1
1973 2
1974 3
1975 3
1976 5
1977 6
1978 3
1979 1
1980 3
1981 11
1982 6
1983 15
1984 8
1985 3
1986 9
1987 7
1988 7
1989 11
1990 14
1991 27
1992 29
1993 21
1994 35
1995 21
1996 20
1997 30
1998 36
1999 42
2000 45
2001 48
2002 41
2003 44
2004 39
2005 51
2006 63
2007 62
2008 71
2009 80
2010 94
2011 115
2012 144
2013 174
2014 171
2015 220
2016 223
2017 247
2018 270
2019 333
2020 337
2021 399
2022 407
2023 391
2024 160

Text availability

Article attribute

Article type

Publication date

Search Results

4,162 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Omipidam
Page 1
Associations Between Life's Essential 8 and Chronic Kidney Disease.
Ren Y, Cai Z, Guo C, Zhang Y, Xu H, Liu L, Wang L, Ba Y, Liu S, Zhang G, Liu Z, Han X. Ren Y, et al. Among authors: ba y. J Am Heart Assoc. 2023 Dec 19;12(24):e030564. doi: 10.1161/JAHA.123.030564. Epub 2023 Dec 8. J Am Heart Assoc. 2023. PMID: 38063194 Free PMC article.
Idiopathic Familial Acro-osteolysis.
Ba X, Zhang G, Guo H. Ba X, et al. Mayo Clin Proc. 2023 Oct;98(10):1527-1528. doi: 10.1016/j.mayocp.2023.05.015. Mayo Clin Proc. 2023. PMID: 37793727 No abstract available.
First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors.
Zhao Y, Ma Y, Zang A, Cheng Y, Zhang Y, Wang X, Chen Z, Qu S, He J, Chen C, Jin C, Zhu D, Li Q, Liu X, Su W, Ba Y, Hao Y, Chen J, Zhang G, Qu S, Li Y, Feng W, Yang M, Liu B, Ouyang W, Liang J, Yu Z, Kang X, Xue S, Yang G, Yan W, Yang Y, Liu Z, Peng Y, Fanslow B, Huang X, Zhang L, Zhao H. Zhao Y, et al. Among authors: ba y. J Hematol Oncol. 2023 May 8;16(1):50. doi: 10.1186/s13045-023-01445-1. J Hematol Oncol. 2023. PMID: 37158938 Free PMC article. Clinical Trial.
T peripheral helper cells in autoimmune diseases: What do we know?
Huang Y, Ba X, Han L, Wang H, Lin W, Chen Z, Tu S. Huang Y, et al. Among authors: ba x. Front Immunol. 2023 Apr 3;14:1145573. doi: 10.3389/fimmu.2023.1145573. eCollection 2023. Front Immunol. 2023. PMID: 37077922 Free PMC article. Review.
Dyslipidemia in rheumatoid arthritis: the possible mechanisms.
Yan J, Yang S, Han L, Ba X, Shen P, Lin W, Li T, Zhang R, Huang Y, Huang Y, Qin K, Wang Y, Tu S, Chen Z. Yan J, et al. Among authors: ba x. Front Immunol. 2023 Oct 25;14:1254753. doi: 10.3389/fimmu.2023.1254753. eCollection 2023. Front Immunol. 2023. PMID: 37954591 Free PMC article. Review.
Pan-cancer analysis of G6PD carcinogenesis in human tumors.
Liu B, Fu X, Du Y, Feng Z, Chen R, Liu X, Yu F, Zhou G, Ba Y. Liu B, et al. Among authors: ba y. Carcinogenesis. 2023 Aug 18;44(6):525-534. doi: 10.1093/carcin/bgad043. Carcinogenesis. 2023. PMID: 37335542
Recent Progress in CDK4/6 Inhibitors and PROTACs.
Wang H, Ba J, Kang Y, Gong Z, Liang T, Zhang Y, Qi J, Wang J. Wang H, et al. Among authors: ba j. Molecules. 2023 Dec 13;28(24):8060. doi: 10.3390/molecules28248060. Molecules. 2023. PMID: 38138549 Free PMC article. Review.
4,162 results